Evidence map›Paper›PMID 39684907›Full record

ArticleInternational journal of molecular sciences2024

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity.

Serena Spartano, Maria Vittoria Faggiano, Giovanna Guidi, Pino D'Ambrosio, Alessandro Vaisfeld, Agnese Novelli, Salvatore Falqui, Antonella Cingolani, Lorenza Lambertenghi, Alessandro Visentin and 12 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Serena SpartanoSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-7095-9968
Maria Vittoria FaggianoSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.
Giovanna GuidiSection of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.
Pino D'AmbrosioSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0009-0009-0640-4923
Alessandro VaisfeldSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.
Agnese NovelliSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-2889-6967
Salvatore FalquiSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.
Antonella CingolaniSection of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.
Lorenza LambertenghiInfectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-6921-0522
Alessandro VisentinInfectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-5097-8750
Annamaria AzziniInfectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-7148-2559
Elda RighiInfectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Enrico Maria TrecarichiInfectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, University "Magna Graecia"-"R. Dulbecco", 88100 Catanzaro, Italy.ORCID 0000-0001-9064-7745
Maria MazzitelliInfectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, University "Magna Graecia"-"R. Dulbecco", 88100 Catanzaro, Italy.
Silvano ColettiChelonia SA, 6900 Lugano, Switzerland.ORCID 0000-0002-8754-0434
Jan MousChelonia SA, 6900 Lugano, Switzerland.
Thomas W RademacherDivision of Infection and Immunity, University College London and Middlesex University, London WC1E 6BT, UK.
Carlo TortiSection of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.
Evelina TacconelliInfectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Massimo FantoniSection of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0000-0001-6913-8460
Roberto CaudaSection of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-1498-4229
Francesco Danilo TizianoSection of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-5545-6158

Funding

Emergex Vaccines Ltd 0000
6 · The paper itself

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, responsible for Coronavirus Disease 2019 (COVID-19), exhibits a spectrum of clinical manifestations, ranging from asymptomatic to severe pulmonary dysfunction or death. The variability in COVID-19 severity has largely been attributed to the host's genetic characteristics, suggesting a polygenic genetic architecture, without significant strong evidence of sex-related genetic differences. In this Italian retrospective case-control study, we investigated the association between COVID-19 severity (severe vs. asymptomatic/oligosymptomatic healed individuals) and HLA gene variants, analyzed by next-generation sequencing (NGS). We identified significant HLA alleles (according to the conventional nomenclature), SNPs and haplotypes in the

Indexed as

AllelesCOVID-19Genetic Predisposition to DiseaseHaplotypesHLA AntigensSARS-CoV-2Severity of Illness IndexAdultAgedCase-Control StudiesFemaleGene FrequencyHumansItalyMaleMiddle AgedHLA Antigensbiological sex differencescase–control studyCOVID-19genetic architecturegenetic association studyHLA gene variantsimmune system modulationnext-generation sequencingSARS-CoV-2

Identifiers

PMID39684907
PMCPMC11642212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.